NL-OMON52302招募中不适用
Dose-escalation with MR-guided stereotactic radiotherapy in isolated malignancies in the upper abdomen (RADIOPANC): a phase I dose finding trial - RADIOPANC
niversitair Medisch Centrum Utrecht0 个研究点目标入组 18 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Either patients with an unresectable, isolated malignancy (primary tumor or
- •oligometastasis) or inoperable patients with a resectable, isolated malignancy
- •(primary tumor or oligometastasis) in the upper abdominal region;
- •- Patients referred for SBRT by a multidisciplinary consultation of medical
- •specialists for local control or palliative care;
- •- Performance status WHO 0-2 with a minimal expected lifespan of >6 months;
- •- Written informed consent.
排除标准
- •- Age <18 years;
- •- Ineligibility for MRI according to the protocol of the local radiology
- •department;
- •- Pregnancy;
- •- Radiotherapy as neoadjuvant treatment;
- •- >= 1 cm extensive tumor growth into the lumen of healthy hollow organs.
研究者
相似试验
招募中
2 期
Stereotactic MR-guided Adaptive Radiation Therapy (SMART) for localized prostate cancer; a phase II studycarcinoma of the prostate10038364prostate cancerNL-OMON42880Vrije Universiteit Medisch Centrum100
进行中（未招募）
2 期
MR-Guided Adaptive Stereotactic Body Radiotherapy (SBRT) of Primary Tumor for Pain Control in Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) – a Randomized, Controlled Clinical StudyC25Malignant neoplasm of pancreasDRKS00025801MU Klinikum10
进行中（未招募）
不适用
Stereotactic accelerated radiotherapy concurrent with Temozolomide chemotherapy in newly diagnosed glioblastoma - NDEUCTR2009-015614-21-ITISTITUTO NEUROLOGICO CARLO BESTA
撤回
不适用
Phase I Study MR-guided SBRT to PCaLow or Intermediate Risk Prostate CancerNCT03935308Henry Ford Health System
已完成
2 期
Addition of stereotactic radiotherapy to the standard FOLFIRINOX treatment in locally advanced pancreatic cancer patients to determine efficacy and feasability (LAPC-1)locally advanced pancreatic carcinoma1001567410017991Pancreatic cancerNL-OMON44466Stichting Leveronderzoek51